Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.625 USD | -2.82% | +0.69% | +73.70% |
Mar. 19 | Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants | MT |
Mar. 15 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 64.25M | Sales 2025 * | 251M | Capitalization | 2.2B |
---|---|---|---|---|---|
Net income 2024 * | -214M | Net income 2025 * | -110M | EV / Sales 2024 * | 33.5 x |
Net cash position 2024 * | 45.95M | Net cash position 2025 * | 435M | EV / Sales 2025 * | 7.01 x |
P/E ratio 2024 * |
-10.8
x | P/E ratio 2025 * |
-21.9
x | Employees | 141 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.91% |
Latest transcript on Geron Corporation
1 day | +1.36% | ||
1 week | -1.06% | ||
Current month | +13.03% | ||
1 month | +17.48% | ||
3 months | +98.40% | ||
6 months | +110.73% | ||
Current year | +76.78% |
Managers | Title | Age | Since |
---|---|---|---|
John Scarlett
CEO | Chief Executive Officer | 73 | 11-09-28 |
Director of Finance/CFO | 57 | 23-09-24 | |
Faye Feller
CTO | Chief Tech/Sci/R&D Officer | 42 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
V. Lawlis
BRD | Director/Board Member | 72 | 12-03-14 |
John Scarlett
CEO | Chief Executive Officer | 73 | 11-09-28 |
Susan Molineaux
BRD | Director/Board Member | 70 | 12-09-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 3.669 | -1.64% | 3 248 891 |
24-04-18 | 3.73 | +1.36% | 9,740,360 |
24-04-17 | 3.68 | +2.79% | 9,649,835 |
24-04-16 | 3.58 | +3.77% | 6,439,992 |
24-04-15 | 3.45 | -5.22% | 11,913,586 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.78% | 2.2B | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.27% | 21.66B | |
-18.35% | 20.77B | |
-8.28% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- GERN Stock